##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 111 Download : 79

##plugins.themes.academic_pro.article.main##

Abstract

The transformation of an ordinary cell into a cancerous one could be a dynamic process which often involves the approval of oncogenes as well as deactivation of tumor suppressor properties (alterations). Most changes are emptied by cellular genome dauntlessness and repair components. In any case, many genetic changes give cells an advancement advantage and unused capacities, driving to their neoplastic alter. As other cancers, like melanoma, sarcoma, and lymphoma, could affect the colon, colon cancer, also known as colon carcinoma, affects the epithelium of colon. The uncontrolled proliferation regarding colorectal epithelial cells might be a hallmark of colorectal cancer (CRC). The multistep carcinogenesis hypothesis states that pigment cells go through a sequence of atomic alterations before they become totally dangerous cells. The inactivation related to the Adenomatous polyposis coli (APC) signaling pathway is the most frequent hereditary cause of activation. The pathology of damage includes oncogene changes, tumor suppressor qualities, and probably many signaling pathways, which put cancers at risk of metastasis. In advanced nations, CRC has a high disease-specific mortality rate and impacts over a million individuals annually. Worldwide, CRC ranks 3 rd in terms of the incidence in both women and men. Africa and Central and South Asia have experienced the biggest drops in CRC, whereas New Zealand, Australia, North America, and Europe have experienced highest change rates.

Keywords

colon cancer Histopathological Risk factors

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Sabreen S. Abd Alkreem Alsaqi. (2023). The relationships between Risk Factors and the changes of Histopathological of Tissue Colon Cancer in Iraq Patients. Texas Journal of Medical Science, 27, 47–56. https://doi.org/10.62480/tjms.2023.vol27.pp47-56
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Gartner, L. P. and Hiatt, J. L. (2012). Color atlas and text of histology. Lippincott Williams and Wilkins.
  2. -Mescher, A. L. 2010. Junqueira's basic histology: text & atlas. McGraw- Hill Medical New York.
  3. - Welsch, U. (2006). Sobotta Lehrbuch Histologie mit StudentConsult-Zugang: Zytologie, Histologie, Mikroskopische Anatomie. Student Consult. Elsevier, Urban and FischerVerlag.
  4. -Schünke, M., Schulte, E. and Schumacher, U. (2009). Prometheus–LernAtlas der Anatomie: Innere Organe. Illustrationen von M. Voll und K. Wesker, Stuttgart: Thieme.
  5. -Hamilton S.R., Bosman F.T., Carmeiro F., Hruban R.H. and Boffetta P. (2010). Carcinoma of the colon and rectum in: WHO classification of tumors of the digestive system. Thesis MD, eds. Lyon: IARC press. 134-46.
  6. -Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. and Nagle, R. B. (2000). Prognostic factors in colorectal cancer. Arch Pathol Lab Med 124(7): 979-994.
  7. -Leopoldo, S., Lorena, B., Cinzia, A., Luciana, B. A., Renato, C., Antonio, M., Carlo, S., Cristina, P., Stefano, C. and Maurizio, T. (2008). Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Annals of surgical oncology 15(5): 1429-1439.
  8. -Chen, J.-S., Hsieh, P.-S., Chiang, J.-M., Yeh, C.-Y., Tsai, W.-S., Tang, R., Changchien, C.-R. and Wu, R.-C. (2010). Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon. Chang Gung Med J 33(1): 51-57
  9. -Thirunavukarasu, P., Sathaiah, M., Singla, S., Sukumar, S., Karunamurthy, A., Pragatheeshwar, K. D., Lee, K. K., Zeh, H., Kane, K. M. and Bartlett, D. L. (2010). Medullary carcinoma of the large intestine: a population based analysis. International journal of oncology 37(4): 901-907.
  10. - Bailey, H. R. (2013). Colorectal surgery. http://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20090420579
  11. -Rowan,W. and Parks. (2012). principals and practice of surgery 6th ed., Elsevier Ltd
  12. -Siegel, R. L., Miller, K. D. & Jemal, A. (2015). Cancer statistics, 2015. CA: a cancer journal for clinicians 65(1): 5-29
  13. - Iraqi cancer registry, (2010). Republic of Iraq, Ministry of Health cancer board.
  14. -Mohandas, K. (2011). Colorectal cancer in India: controversies, enigmas and primary prevention. Indian Journal of Gastroenterology 30(1): 3-6.
  15. -Basaleem, H. O. and Al-Sakkaf, K. A. (2004). Colorectal cancer among Yemeni patients. Characteristics and trends. Saudi medical journal 25(8): 1002-1005
  16. -Rasul, K. I., Awidi, A. S., Mubarak, A. A. and Al-Homsi, U. M. (2001). Study of colorectal cancer in Qatar. Saudi medical journal 22(8): 705-707.
  17. -Gado, A., Ebeid, B., Abdelmohsen, A. and Axon, A. (2014). Colorectal cancer in Egypt is commoner in young people: Is this cause for alarm? Alexandria Journal of Medicine 50(3): 197-201.
  18. -Morris, E., Penegar, S., Whitehouse, L., Quirke, P., Finan, P., Bishop, D., Wilkinson, J. and Houlston, R. (2013). A retrospective observational study of the relationship between family history and survival from colorectal cancer. British journal of cancer 108(7): 1502-1507.
  19. -Lynch, H. T. and de la Chapelle, A. (2003). Hereditary colorectal cancer. N Engl J Med 348(10): 919-932.
  20. -Win, A. K., Lindor, N. M., Young, J. P., Macrae, F. A., Young, G. P., Williamson, E., Parry, S., Goldblatt, J., Lipton, L. and Winship, I. (2012). Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. Journal of the National Cancer Institute: p351.
  21. -Jasperson, K. W., Tuohy, T. M., Neklason, D. W. and Burt, R. W. (2010). Hereditary and familial colon cancer. Gastroenterology 138(6): 2044-2058.
  22. -Galiatsatos, P. and Foulkes, W. D. (2006). Familial adenomatous polyposis. The American journal of gastroenterology 101(2): 385-398.
  23. -Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Clendenning, M., Sotamaa, K., Prior, T. and Westman, J. A. (2008). Feasibility of screening for Lynch syndrome among
  24. -Mysliwiec P.A., Cronin K.A. and Schatzkin A. (2006). Chapter 5: New Malignancies Following Cancer of the Colon, Rectum, and Anus. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute.
  25. -Phipps, A. I., Chan, A. T. and Ogino, S. (2013). Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers. Cancer 119(17): 3140-3147.
  26. -Schatzkin, A., Freedman, L. S., Dawsey, S. M. and Lanza, E. (1994). Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. Journal of the National Cancer Institute 86(14): 1053-1057.
  27. -Imperiale, T. F. and Ransohoff, D. F. (2012). Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Annals of internal medicine 156(10): 703-709.
  28. -Bernstein, C. N., Blanchard, J. F., Kliewer, E. and Wajda, A. (2001). Cancer risk in patients with inflammatory bowel disease. Cancer 91(4): 854-862.
  29. -Eaden, J., Abrams, K. and Mayberry, J. (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48(4): 526-535.
  30. -Campbell, P. T., Deka, A., Jacobs, E. J., Newton, C. C., Hildebrand, J. S., McCullough, M. L., Limburg, P. J. and Gapstur, S. M. (2010). Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 139(4): 1138-1146.
  31. -Larsson, S. C., Giovannucci, E. and Wolk, A. (2005). Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 28(7): 1805-1807.
  32. -Luo, W., Cao, Y., Liao, C. and Gao, F. (2012). Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta‐analysis of 24 cohort studies. Colorectal Disease 14(11): 1307-1312.
  33. -Boyle, T., Keegel, T., Bull, F., Heyworth, J. and Fritschi, L. (2012). Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. Journal of the National Cancer Institute: 354.
  34. -Campbell, P. T., Patel, A. V., Newton, C. C., Jacobs, E. J. and Gapstur, S. M. (2013). Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. Journal of Clinical Oncology: JCO. 2012.2045. 9735.
  35. -Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. and Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 371(9612): 569-578.
  36. -Aleksandrova, K., Pischon, T., Buijsse, B., May, A. M., Peeters, P. H., Bueno-de-Mesquita, H. B., Jenab, M., Fedirko, V., Dahm, C. C. and Siersema, P. D. (2013). Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. European Journal of Cancer 49(16): 3526-3536.
  37. -Centers for Disease Control and Prevention (2013). Early Release of Selected Estimates Based on Data From the 2012 National Health Interview Survey. National Center for Health Statistics.
  38. -Cross, A. J., Ferrucci, L. M., Risch, A., Graubard, B. I., Ward, M. H., Park, Y., Hollenbeck, A. R., Schatzkin, A. and Sinha, R. (2010). A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer research 70(6): 2406-2414.
  39. -Secretan, B., Straif, K., Baan, R., Grosse, Y., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C. and Galichet, L. (2009). A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. The lancet oncology 10(11): 1033-1034.
  40. -Liang, P. S., Chen, T. Y. and Giovannucci, E. (2009). Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis. International journal of cancer 124(10): 2406-2415.
  41. -Ferrari, P., Jenab, M., Norat, T., Moskal, A., Slimani, N., Olsen, A., Tjønneland, A., Overvad, K., Jensen, M. K. and Boutron‐Ruault, M. C. (2007). Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). International journal of cancer 121(9): 2065-2072.
  42. -Cook, N. R., Lee, I.-M., Zhang, S. M., Moorthy, M. V. and Buring, J. E. (2013). Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Annals of internal medicine 159(2): 77-85.
  43. -Murphy, G., Devesa, S. S., Cross, A. J., Inskip, P. D., McGlynn, K. A. and Cook, M. B. (2011). Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. International journal of cancer 128(7): 1668-1675.
  44. -Wong, R. J. (2010). Marked variations in proximal colon cancer survival by race/ethnicity within the United States. Journal of clinical gastroenterology 44(9): 625-630.
  45. -American Cancer Society. (2015). Cancer Facts and Figures. Atlanta, Ga: American Cancer Society. Inflamm Bowel Dis., 16:1097–1107.
  46. -Danesi, P. and Telleria, D. (2010). Radiological conditions at four selected sites in South Iraq with residues of depleted uranium. Proceedings of IRPA12: 12. Congress of the International Radiation Protection Association: Strengthening Radiation Protection Worldwide-Highlights, Global Perspective and Future Trends
  47. -Peterson, S. (1999). A special report—The trail of a bullet—Will America risk use of DU in Kosovo. DU‘s global spread spurs debate over effects on humans—A rare visit to Iraq‘s radioactive battlefield—DU‘s fallout in Iraq, Kuwait: a rise in illness
  48. -Little, J. B. (2000). Chapter 14: Ionizing Radiation. Cancer medicine, 6th edn. BC Decker, Hamilton
  49. -Greene, F. L., Page, D., Fleming, I., Fritz, A., Balch, C. and Haller, D. (2002). American Joint Committee on Cancer. AJCC cancer staging manual: xiv.
  50. -Schoen, R. E. (2000). Families at risk for colorectal cancer: risk assessment and genetic testing. Journal of clinical gastroenterology 31(2): 114-120.
  51. - Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D. and Buchanan, D. (2006). CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature genetics 38(7): 787-793.
  52. - Willis, A., Jung, E. J., Wakefield, T. and Chen, X. (2004). Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene 23(13): 2330-2338.
  53. - He, X., Liao, J., Liu, F., Yan, J., Yan, J., Shang, H., Dou, Q., Chang, Y., Lin, J. and Song, Y. (2015). Functional repair of p53 mutation in colorectal cancer cells using trans-splicing. Oncotarget 6(4): 2034.
  54. - Olivier, M. and Taniere, P. (2011). Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes. Current opinion in oncology 23(1): 88-92.
  55. - Iacopetta, B., Russo, A., Bazan, V., Dardanoni, G., Gebbia, N., Soussi, T., Kerr, D., Elsaleh, H., Soong, R. and Kandioler, D. (2006). Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Annals of oncology 17(5): 842-847.